$36.77
-0.03 (-0.08%)
Merck & Co., Inc. (MRK)
CAPS Rating:
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

RSS Headlines
Fool UK
Recs
Merck is currently depressed in value and qualifies as a value purchase. It pays an excellent dividend and seems to have weathered the legal storms over Vytorin and Vioxx. A safe harbor in stormy times.